CTF funding of NF research leads the way to better diagnostic criteria and improved clinical care.
Fueling Innovation CTF Discovery Fund
The Children’s Tumor Foundation Discovery Fund for NF Research is an $8 million investment over 3-5 years that will fund a minimum of 45 new research studies, and accelerate drug discovery for neurofibromatosis. This initiative is set up to attract and invest in the best and brightest minds, who will advance our goal of bringing new treatments to patients faster and more efficiently.
The Young Investigator Award (YIA) The YIA is the Foundation’s oldest research award program and serves to advance understanding of the biology of NF1, NF2, and schwannomatosis, as well as bringing young researchers into the NF field. This award program is one reason the understanding of NF has grown so rapidly. Many of the Foundation’s past YIA awardees have gone on to pursue lifelong careers in the field of NF research.
Drug Discovery Initiative Registered Reports (DDI-RR) Through collaboration with a top scientific journal, PLOS ONE, in a process known as “Registered Reports,” CTF awardees are offered the Foundation’s financial support as well as in-principle acceptance for publication by the journal. This model will allow for more rigorous, reproducible, and transparent science, while guaranteeing its awardees an inprinciple acceptance to publication regardless of study outcome. This award evolved from the Foundation’s classic Drug Discovery Initiative Award program.
14 |
ANNUAL REPORT 2020
